Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:AYRWFOTCMKTS:JUSHFNASDAQ:MDWD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAYRWFAyr Wellness$0.15-37.0%$0.20$0.09▼$2.60$17.43M1.44399,122 shs90,340 shsJUSHFJushi$0.28-5.4%$0.33$0.22▼$0.69$54.27M-1.1853,353 shs62,764 shsMDWDMediWound$19.09-1.7%$19.36$13.49▼$24.00$206.32M0.3891,057 shs55,739 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAYRWFAyr Wellness0.00%+7.14%-38.20%-7.52%-92.39%JUSHFJushi0.00%+0.36%-15.54%+2.22%-53.22%MDWDMediWound0.00%-6.51%-6.15%+17.33%+30.84%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAYRWFAyr Wellness1.6188 of 5 stars3.33.00.00.00.00.01.3JUSHFJushi1.0015 of 5 stars0.03.00.00.02.81.70.6MDWDMediWound1.5658 of 5 stars3.51.00.00.00.00.80.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAYRWFAyr Wellness 2.50Moderate Buy$3.001,900.00% UpsideJUSHFJushi 1.50ReduceN/AN/AMDWDMediWound 3.00Buy$31.8066.58% UpsideCurrent Analyst Ratings BreakdownLatest AYRWF, JUSHF, and MDWD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/2/2025MDWDMediWoundOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$34.005/22/2025MDWDMediWoundHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$25.00 ➝ $31.005/2/2025MDWDMediWoundAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$25.00(Data available from 6/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAYRWFAyr Wellness$463.63M0.04N/AN/A$3.14 per share0.05JUSHFJushi$257.52M0.21N/AN/A($0.26) per share-1.06MDWDMediWound$20.22M10.21N/AN/A$2.89 per share6.61Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAYRWFAyr Wellness-$359.31M-$3.26N/AN/AN/A-77.50%-31.73%-11.73%N/AJUSHFJushi-$48.78M-$0.24N/AN/AN/A-18.54%N/A-10.71%8/6/2025 (Estimated)MDWDMediWound-$30.22M-$2.09N/AN/AN/A-110.45%-74.12%-30.92%8/13/2025 (Estimated)Latest AYRWF, JUSHF, and MDWD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2025Q1 2025MDWDMediWound-$0.65-$0.07+$0.58-$0.07$5.20 million$3.96 million5/8/2025Q1 2025JUSHFJushi-$0.06-$0.09-$0.03-$0.09$66.23 million$63.85 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAYRWFAyr WellnessN/AN/AN/AN/AN/AJUSHFJushiN/AN/AN/AN/AN/AMDWDMediWoundN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAYRWFAyr Wellness1.101.600.57JUSHFJushiN/A1.130.57MDWDMediWoundN/A2.151.99Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAYRWFAyr Wellness0.91%JUSHFJushi21.68%MDWDMediWound46.83%Insider OwnershipCompanyInsider OwnershipAYRWFAyr Wellness8.10%JUSHFJushi22.48%MDWDMediWound9.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAYRWFAyr Wellness2,440116.18 million106.77 millionNot OptionableJUSHFJushi1,234196.63 million152.43 millionNot OptionableMDWDMediWound8010.81 million9.81 millionOptionableAYRWF, JUSHF, and MDWD HeadlinesRecent News About These CompaniesMediWound Ltd. (NASDAQ:MDWD) Shares Acquired by Silverberg Bernstein Capital Management LLCJune 3, 2025 | marketbeat.comCompanies Like MediWound (NASDAQ:MDWD) Are In A Position To Invest In GrowthJune 2, 2025 | finance.yahoo.comMediWound Ltd. (NASDAQ:MDWD) Given Average Rating of "Buy" by AnalystsJune 2, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Coverage Initiated at OppenheimerJune 2, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for MediWound Q2 Earnings?May 27, 2025 | marketbeat.comNorthern Trust Corp Has $2.58 Million Holdings in MediWound Ltd. (NASDAQ:MDWD)May 26, 2025 | marketbeat.comHC Wainwright Forecasts Strong Price Appreciation for MediWound (NASDAQ:MDWD) StockMay 24, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Stock Crosses Above Fifty Day Moving Average - What's Next?May 24, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Releases Earnings Results, Beats Estimates By $0.58 EPSMay 23, 2025 | marketbeat.comMediWound’s Q1 2025: Strategic Progress Amid Financial ChallengesMay 22, 2025 | tipranks.comMediWound (MDWD) Q1 2025 Earnings Call TranscriptMay 21, 2025 | msn.comMediWound Ltd. (MDWD) Q1 2025 Earnings Call TranscriptMay 21, 2025 | seekingalpha.comMediWound (MDWD) Reports Q1 Loss, Misses Revenue EstimatesMay 21, 2025 | zacks.comMediWound Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 21, 2025 | globenewswire.comMediWound Q1 2025 Earnings PreviewMay 20, 2025 | msn.comMediWound Ltd.: Undervalued High-Growth PotentialMay 16, 2025 | seekingalpha.comMediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg UlcersMay 13, 2025 | globenewswire.comMediWound to Report First Quarter 2025 Financial ResultsMay 5, 2025 | globenewswire.comMediWound to Present New EscharEx® Data at Leading Wound Care ConferencesApril 28, 2025 | globenewswire.comThose who invested in MediWound (NASDAQ:MDWD) five years ago are up 30%April 17, 2025 | finance.yahoo.comMediWound reports Q4 EPS (36c), consensus (61c)March 20, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAYRWF, JUSHF, and MDWD Company DescriptionsAyr Wellness OTCMKTS:AYRWF$0.15 -0.09 (-36.97%) As of 06/20/2025 03:59 PM EasternAyr Wellness Inc. operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.Jushi OTCMKTS:JUSHF$0.28 -0.02 (-5.41%) As of 06/20/2025 03:58 PM EasternJushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.MediWound NASDAQ:MDWD$19.09 -0.34 (-1.75%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$19.14 +0.05 (+0.24%) As of 06/20/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
